Clinical trial
131-I-TM-601 Study in Adults With Recurrent High-Grade Glioma
NCT00114309 · TransMolecular, Industry · Unknown status
Key facts
| NCT number | NCT00114309 |
|---|---|
| Title | 131-I-TM-601 Study in Adults With Recurrent High-Grade Glioma |
| Official title | A Phase II Open-Label, Multiple-Dose Study of Intracavitary Administered 131-I-TM-601 in Adult Patients With Recurrent High-Grade Glioma |
| Lead sponsor | TransMolecular, Industry |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Malignant Glioma, Glioblastoma Multiforme, GBM, Anaplastic Astrocytoma, Oligo-Astrocytoma, Gliosarcoma |
| Intervention type | Drug |
| Interventions | 131-I-TM-601, 131I-TM601 |
| Enrollment | 66 |
| Start date | Nov 1, 2004 |
| Primary completion | Mar 1, 2009 |
| Completion | Aug 1, 2009 |
| First posted | Jun 14, 2005 |
| Last update posted | Apr 3, 2009 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: